| Literature DB >> 33256761 |
A Faragli1,2,3,4, R Tanacli1,4, C Kolp1, D Abawi1, T Lapinskas4,5, C Stehning6, B Schnackenburg6, F P Lo Muzio7,8, L Fassina9, B Pieske1,2,3,4, E Nagel10, H Post1,2,3,11, S Kelle1,2,3,4, A Alogna12,13,14.
Abstract
BACKGROUND: Cardiovascular magnetic resonance (CMR) strain imaging is an established technique to quantify myocardial deformation. However, to what extent left ventricular (LV) systolic strain, and therefore LV mechanics, reflects classical hemodynamic parameters under various inotropic states is still not completely clear. Therefore, the aim of this study was to investigate the correlation of LV global strain parameters measured via CMR feature tracking (CMR-FT, based on conventional cine balanced steady state free precession (bSSFP) images) with hemodynamic parameters such as cardiac index (CI), cardiac power output (CPO) and end-systolic elastance (Ees) under various inotropic states.Entities:
Keywords: Cardiovascular magnetic resonance; Contractile function; Feature tracking; Hemodynamics; Left ventricular strain; Porcine model; Translational studies
Year: 2020 PMID: 33256761 PMCID: PMC7708216 DOI: 10.1186/s12968-020-00679-z
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Global strain analysis via Qstrain and representative left ventricular (LV) strain curves from one experiment. a Short axis endocardial and epicardial contouring; b circumferential strain measured with Qstrain, the lower end of the scale bar is equal to zero and it is not represented in the original window from MEDIS; c circumferential strain measured at end-systole time-to-peak; d longitudinal axis endocardial contouring; e longitudinal strain measured with Qstrain, the lower end of the scale bar is equal to zero and it is not represented in the original window from MEDIS; f longitudinal strain measured at end-systole time-to-peak; g global longitudinal strain (GLS), h global circumferential strain (GCS), and i global radial strain (GRS) representative curves from one animal measured during Baseline, Dobutamine (Dob) and Verapamil (Ver) (mean values of all segments)
Global peak systolic strain rates values measured at different inotropic states
| Baseline | Dobutamine | Verapamil | |
|---|---|---|---|
| GLS peak systolic SR (s-1) | − 2.5 ± 0.6 | − 6.4 ± 1.5* | − 2.1 ± 1.1§ |
| GCS peak systolic SR (s-1) | − 3.2 ± 2.2 | − 8.7 ± 2.5* | − 2.0 ± 1.3§ |
| GRS peak systolic SR (s-1) | 2.7 ± 1.0 | 5.5 ± 0.9 | 2.2 ± 1.5§ |
Strain Rate (SR). *p < 0.05 vs. Baseline; §p < 0.05 vs. Dobutamine
Systemic hemodynamics and cardiac mechanics parameters during BL, Dob and Ver steps
| Baseline | Dobutamine | Verapamil | |
|---|---|---|---|
| HR (bpm) | 106 ± 15 | 146 ± 12* | 98 ± 19*,§ |
| LVEF (%) | 59 ± 8 | 77 ± 7* | 39 ± 9*,§ |
| CO (L/min) | 6 ± 1 | 9 ± 2* | 4 ± 1*,§ |
| CI (L/min/m2) | 2.5 ± 0.2 | 3.8 ± 0.5* | 1.7 ± 0.7*,§ |
| CPO (W) | 1.2 ± 0.3 | 2.0 ± 0.6* | 0.7 ± 0.2*,§ |
| SVR (dyn s cm−5) | 15 ± 5 | 11 ± 4* | 19 ± 9*,§ |
| mAoP (mmHg) | 90 ± 12 | 98 ± 19 | 70 ± 10*,§ |
| Wall stress (mmHg) | 0.12 ± 0.02 | 0.16 ± 0.04* | 0.10 ± 0.02§ |
HR heart rate, LVEF left ventricular ejection fraction, CO cardiac output, CI cardiac index, CPO cardiac power output, SVR systemic vascular resistance, mAoP mean aortic pressure
*p < 0.05 vs. Baseline; §p < 0.05 vs. Dobutamine
Fig. 2Averaged end-systolic pressure–volume relationship at baseline, during dobutamine and verapamil. Single-loop derived by the LV end-systolic pressure–volume relationship (ESPVR) is plotted under various inotropic states. The green line corresponds to the averaged ESPVR during dobutamine infusion, the blue line represents the averaged ESPVR at baseline, while the red one represented the averaged ESPVR at verapamil. A steeper increase in ESPVR during dobutamine and a relevant decrease during verapamil are observed. The equation for each ESPVR is displayed in the graph. Data points are plotted for each animal during different inotropic states. The dashed lines represent the 95% confidence intervals
Global strain and indexed global strain values measured at different inotropic states
| Baseline | Dobutamine | Verapamil | |
|---|---|---|---|
| (A) | |||
| GLS (%) | − 23 ± 4 | − 45 ± 9* | − 16 ± 3*,§ |
| GCS (%) | − 31 ± 8 | − 53 ± 10* | − 17 ± 5*,§ |
| GRS (%) | 72 ± 19 | 88 ± 36 | 30 ± 12*,§ |
| (B) | |||
| GLSi (%) | − 23 ± 4 | − 45 ± 10* | − 16 ± 4*,§ |
| GCSi (%) | − 30 ± 8 | − 52 ± 8* | − 16 ± 5*,§ |
| GRSi (%) | 71 ± 19 | 84 ± 23 | 30 ± 13*,§ |
| (C) | |||
| GLSw (%) | − 23 ± 5 | − 44 ± 10* | − 16 ± 3*,§ |
| GCSw (%) | − 31 ± 9 | − 52 ± 13* | − 17 ± 17*,§ |
| GRSw (%) | 71 ± 20 | 90 ± 54 | 35 ± 27*,§ |
(A) Global strain: GLS global longitudinal strain, GCS global circumferential strain, GRS global radial strain; (B) Global strain indexed for mean aortic pressure (mAoP): GLSi global longitudinal strain indexed for mAoP, GCSi global circumferential strain indexed for mAOP, GRSi global radial strain indexed for mAoP; (C) Global strain indexed for meridional wall stress: GLSw global longitudinal strain indexed for wall stress, GCSw global circumferential strain indexed for wall stress, GRSw global radial strain indexed for wall stress. *p < 0.05 vs. baseline; §p < 0.05 vs. Dobutamine
Fig. 3Correlation between global strain and different invasive parameters of hemodynamics. a Linear regression analysis showing a moderate correlation between GLS, GCS, and CI; and a poor correlation between GRS and CI. b Linear regression analysis showing a moderate correlation between GLS, GCS and CPO; and a poor correlation between GRS and CPO. c Linear regression analysis showing a moderate correlation between GLS, GCS, and Ees; and a poor correlation between GRS and Ees. Blue dots represent BL baseline, green dots represent Dob dobutamine, red dots represent Ver verapamil
Fig. 4Correlation between global strain indexed for mean aortic pressure and different invasive parameters of hemodynamics. Linear correlation between GLSi, GCSi, GRSi; and CI (a), CPO (b), and Ees (c), after adjusting strain values for mean aortic pressure (mAoP), according to the following formula (Global Strain × mAOP/avg (mAoP). Blue dots represent BL baseline, green dots represent Dob dobutamine, red dots represent Ver verapamil. GLSi global longitudinal strain indexed for mAoP, GCSi global circumferential strain indexed for mAoP, GRSi global radial strain indexed for mAoP
Fig. 5Correlation between global strain indexed for wall stress and different invasive parameters of hemodynamics. Linear correlation between GLSw, GCSw, GRSw, LVEF; and CI (a), CPO (b), and Ees (c), after adjusting strain values for meridional Wall Stress, according to the following formula (Global Strain × Wall Stress / avg (Wall Stress). Blue dots represent BL baseline, green dots represent Dob dobutamine, red dots represent Ver verapamil
Fig. 6Relative change of global strain and cardiac mechanics parameters from baseline to dobutamine or verapamil. The schematic representation above shows the relative change of global strain values and invasive hemodynamic parameters (dashed box) from baseline (BL, dashed horizontal line) to dobutamine (Dob, green boxes) and from BL to verapamil (Ver, red boxes), respectively. *p < 0.05 vs CI, §p < 0.05 vs GLS, ‡p < 0.05 vs GCS